According to Zhitong Finance App, Jinhe Biotech (002688.SZ) released its report for the third quarter of 2026. The company achieved operating income of 2,094 billion yuan in the first three quarters, up 2.86% year on year; net profit attributable to shareholders of listed companies was 133 million yuan, down 4.29% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 125 million yuan, up 0.39% year on year; basic earnings per share were 0.1713 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.